|
1
|
Wadhwa R, Song S, Lee JS, Yao Y, Wei Q and
Ajani JA: Gastric cancer-molecular and clinical dimensions. Nat Rev
Clin Oncol. 10:643–655. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bertuccio P, Chatenoud L, Levi F, Praud D,
Ferlay J, Negri E, Malvezzi M and La Vecchia C: Recent patterns in
gastric cancer: A global overview. Int J Cancer. 125:666–673. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen J, Bu XL, Wang QY, Hu PJ and Chen MH:
Decreasing seroprevalence of Helicobacter pylori infection during
1993–2003 in Guangzhou, southern China. Helicobacter. 12:164–169.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kawakami E, Machado RS, Ogata SK and
Langner M: Decrease in prevalence of Helicobacter pylori infection
during a 10-year period in Brazilian children. Arq Gastroenterol.
45:147–151. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Meyerhardt JA and Fuchs CS: Adjuvant
therapy in gastric cancer: Can we prevent recurrences? Oncology.
17:714–733. 2003.PubMed/NCBI
|
|
7
|
Gey GO, Coffman WD and Kubicek MT: Tissue
culture studies of the proliferative capacity of cervical carcinoma
and normal epithelium. Cancer Res. 12:264–265. 1952.
|
|
8
|
Barranco SC, Townsend CM Jr, Casartelli C,
Macik BG, Burger NL, Boerwinkle WR and Gourley WK: Establishment
and characterization of an in vitro model system for human
adenocarcinoma of the stomach. Cancer Res. 43:1703–1709.
1983.PubMed/NCBI
|
|
9
|
Motoyama T, Hojo H and Watanabe H:
Comparison of seven cell lines derived from human gastric
carcinomas. Acta Pathol Jpn. 36:65–83. 1986.PubMed/NCBI
|
|
10
|
Park JG, Frucht H, LaRocca RV, Bliss DP
Jr, Kurita Y, Chen TR, Henslee JG, Trepel JB, Jensen RT, Johnson
BE, et al: Characteristics of cell lines established from human
gastric carcinoma. Cancer Res. 50:2773–2780. 1990.PubMed/NCBI
|
|
11
|
Park JG, Yang HK, Kim WH, Chung JK, Kang
MS, Lee JH, Oh JH, Park HS, Yeo KS, Kang SH, et al: Establishment
and characterization of human gastric carcinoma cell lines. Int J
Cancer. 70:443–449. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ku JL, Kim KH, Choi JS, Kim SH, Shin YK,
Chang HJ, Bae JM, Kim YW, Lee JH, Yang HK, et al: Establishment and
characterization of six human gastric carcinoma cell lines,
including one naturally infected with Epstein-Barr virus. Cell
Oncol. 35:127–136. 2012. View Article : Google Scholar
|
|
13
|
Akiyama S, Amo H, Watanabe T, Matsuyama M,
Sakamoto J, Imaizumi M, Ichihashi H, Kondo T and Takagi H:
Characteristics of three human gastric cancer cell lines, NU-GC-2,
NU-GC-3 and NU-GC-4. Jpn J Surg. 18:438–446. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Holliday DL and Speirs V: Choosing the
right cell line for breast cancer research. Breast Cancer Res.
13:2152011. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Burdall SE, Hanby AM, Lansdown MR and
Speirs V: Breast cancer cell lines: Friend or foe? Breast Cancer
Res. 5:89–95. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Osborne CK, Hobbs K and Trent JM:
Biological differences among MCF-7 human breast cancer cell lines
from different laboratories. Breast Cancer Res Treat. 9:111–121.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Capes-Davis A, Theodosopoulos G, Atkin I,
Drexler HG, Kohara A, MacLeod RA, Masters JR, Nakamura Y, Reid YA,
Reddel RR, et al: Check your cultures! A list of cross-contaminated
or misidentified cell lines. Int J Cancer. 127:1–8. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Christgen M and Lehmann U: MDA-MB-435: The
questionable use of a melanoma cell line as a model for human
breast cancer is ongoing. Cancer Biol Ther. 6:1355–1357. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheung PF, Yip CW, Ng LW, Lo KW, Wong N,
Choy KW, Chow C, Chan KF, Cheung TT, Poon RT, et al: Establishment
and characterization of a novel primary hepatocellular carcinoma
cell line with metastatic ability in vivo. Cancer Cell Int.
14:1032014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang JH, Li LF, Yu Y, Li B, Jin HJ, Shen
DH, Li J, Jiang XQ and Qian QJ: Establishment and characterization
of a cell line, EH-GB2, derived from hepatic metastasis of
gallbladder cancer. Oncol Rep. 27:775–782. 2012.
|
|
21
|
Ming SC: Gastric carcinoma. A
pathobiological classification. Cancer. 39:2475–2485. 1977.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma S, Hu L, Huang XH, Cao LQ, Chan KW,
Wang Q and Guan XY: Establishment and characterization of a human
cholangiocarcinoma cell line. Oncol Rep. 18:1195–1200.
2007.PubMed/NCBI
|
|
23
|
Limpaiboon T, Tapdara S, Jearanaikoon P,
Sripa B and Bhudhisawasdi V: Prognostic significance of
microsatellite alterations at 1p36 in cholangiocarcinoma. World J
Gastroenterol. 12:4377–4382. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Uhm KO, Park YN, Lee JY, Yoon DS and Park
SH: Chromosomal imbalances in Korean intrahepatic
cholangiocarcinoma by comparative genomic hybridization. Cancer
Genet Cytogenet. 157:37–41. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wada M, Yokota J, Mizoguchi H, Terada M
and Sugimura T: Y chromosome abnormality in human stomach and lung
cancerJpn. J Cancer Res. 78:780–783. 1987.
|
|
26
|
Yanagihara K, Seyama T, Tsumuraya M,
Kamada N and Yokoro K: Establishment and characterization of human
signet ring cell gastric carcinoma cell lines with amplification of
the c-myc oncogene. Cancer Res. 51:381–386. 1991.PubMed/NCBI
|
|
27
|
Geiger TR and Peeper DS: Metastasis
mechanisms. Biochim Biophys Acta. 1796:293–308. 2009.PubMed/NCBI
|
|
28
|
Boyer B, Vallés AM and Edme N: Induction
and regulation of epithelial-mesenchymal transitions. Biochem
Pharmacol. 60:1091–1099. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kudo-Saito C, Shirako H, Takeuchi T and
Kawakami Y: Cancer metastasis is accelerated through
immunosuppression during Snail-induced EMT of cancer cells. Cancer
Cell. 15:195–206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Batlle E, Sancho E, Francí C, Domínguez D,
Monfar M, Baulida J and García De Herreros A: The transcription
factor snail is a repressor of E-cadherin gene expression in
epithelial tumour cells. Nat Cell Biol. 2:84–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
